Screener
Larimar Therapeutics LRMR Q3 2025 earnings
Reported November 5, 2025 · Before market open
EPS-$0.61Miss by $0.22
EPS estimate-$0.39
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Larimar Therapeutics report Q3 2025 earnings?
- Larimar Therapeutics (LRMR) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were Larimar Therapeutics's Q3 2025 revenue and EPS?
- Larimar Therapeutics reported eps of $-0.61 for Q3 2025.
- Did Larimar Therapeutics beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.39 by $0.22.
- How did Larimar Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 154.2% from $-0.24.
- Where can I find Larimar Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-265702) and the 10-Q periodic report (0001193125-25-266969) directly on SEC EDGAR. The filing index links above go to sec.gov.
